Literature DB >> 8196295

Acute hemodialysis of infants weighing less than five kilograms.

R H Sadowski1, W E Harmon, K Jabs.   

Abstract

The records of 33 infants weighing 5 kg or less who received acute hemodialysis treatment at Children's Hospital between 1980 and 1991 were reviewed. Dialysis was initiated to treat hyperammonemia (8), primary renal or renovascular disease (7), and acute renal failure (18). The infants weighed 2.2 to 4.0 kg at birth and 27% were born prematurely. The infants were 2 to 120 days of age (median 10 days) and weighed 2.2 to 5.0 kg (median 3.5 kg) at the initiation of hemodialysis. Hemodialysis access was achieved via double-lumen 7 French catheters in 49% of the infants, the ECMO circuit in 24%, and the umbilical vessels in 27%. Thirty-three infants underwent a total of 216 hemodialysis treatments. Only nine treatments were discontinued prematurely: six for intractable hypotension and three for technical problems. Fifty-two percent (17 of 33) of the infants survived through the end of the hemodialysis treatment course. The survival rates for the infants with hyperammonemia (75%) and primary renal disease (71%) were better than those for infants with acute renal failure (33%). The survivors did not differ from those who died with respect to birthweight, weight when hemodialysis was initiated, or the number of hemodialysis treatments administered. We conclude that infants weighing less than 5 kg can be treated successfully with hemodialysis. Patient survival is related to underlying medical problems, not to complications of hemodialysis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196295     DOI: 10.1038/ki.1994.119

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

1.  Removal of branched-chain amino acids and alpha-ketoisocaproate by haemofiltration and haemodiafiltration.

Authors:  J B Gouyon; D Semama; A Prévot; J Desgres
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 2.  Managing acute renal failure in very low birthweight infants.

Authors:  M G Coulthard; B Vernon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-11       Impact factor: 5.747

3.  Continuous hemofiltration in the control of neonatal hyperammonemia: a 10-year experience.

Authors:  Claire Westrope; Kevin Morris; David Burford; Gavin Morrison
Journal:  Pediatr Nephrol       Date:  2010-05-22       Impact factor: 3.714

Review 4.  Hyperammonemia in review: pathophysiology, diagnosis, and treatment.

Authors:  Ari Auron; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2011-03-23       Impact factor: 3.714

5.  Kidney support for babies: building a comprehensive and integrated neonatal kidney support therapy program.

Authors:  Tahagod H Mohamed; Jolyn Morgan; Theresa A Mottes; David Askenazi; Jennifer G Jetton; Shina Menon
Journal:  Pediatr Nephrol       Date:  2022-10-13       Impact factor: 3.651

Review 6.  The Role of RRT in Hyperammonemic Patients.

Authors:  Shruti Gupta; Andrew Z Fenves; Robert Hootkins
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

7.  Acute hemodialysis for hyperammonemia in small neonates.

Authors:  Deepak K Rajpoot; John J Gargus
Journal:  Pediatr Nephrol       Date:  2004-03-02       Impact factor: 3.714

8.  Duration of extracorporeal therapy in acute maple syrup urine disease: a kinetic model.

Authors:  Véronique Phan; Marie-José Clermont; Aicha Merouani; Catherine Litalien; Marisa Tucci; Marie Lambert; Grant Mitchell; Philippe Jouvet
Journal:  Pediatr Nephrol       Date:  2006-03-04       Impact factor: 3.714

Review 9.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

10.  Section 5: Dialysis Interventions for Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.